ArticleBMC urology2025
Efficacy of preoperative electroacupuncture for ureteral access sheath placement during first-stage flexible ureteroscopy in urolithiasis: a multicenter, randomized, single-blind, sham-controlled trial protocol.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionRetrograde intrarenal surgery (RIRS) is a primary treatment for urolithiasis, with successful ureteral access sheath (UAS) placement being a critical step. Preliminary studies suggest preoperative electroacupuncture (EA) may enhance UAS placement success, reduce ureteral injury, and improve stone clearance rates. This trial evaluates the efficacy and safety of EA as an adjunct to first-stage RIRS. METHODS AND ANALYSIS: This multicenter, randomized, single-blind, sham-controlled trial will enroll 120 adult patients with upper ureteral or renal stones (≥ 10 mm) scheduled for first-stage RIRS. Participants will be randomized (1:1) to receive either preoperative EA plus general anesthesia or sham EA plus general anesthesia across multiple sessions. The primary outcome is the proportion of patients with successful UAS placement during first-stage RIRS. Secondary outcomes include surgical duration, UAS insertion resistance, ureteral injury (Post-Ureteroscopic Lesion Scale [PULS]), stone clearance rate at 2 weeks post-surgery, and adverse events (AEs) up to 2 weeks post-surgery. Data will be analyzed using intention-to-treat principles. DISCUSSION: This study is the first randomized controlled trial to investigate the efficacy of EA in improving the success rate and safety of UAS placement during first-stage RIRS. The findings will provide high-quality evidence to support the use of EA as an adjunctive therapy in clinical practice. Through a comprehensive multidimensional assessment, this study demonstrates the potential of EA for broader application in the treatment of urolithiasis. Further rigorously designed clinical trials are essential to validate and refine this promising therapeutic approach. REGISTRATION NUMBER: International Traditional Medicine Clinical Trial Registry. Identifier: ITMCTR2025001039.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.